Table 1.
Seroprevalence of EBV antibodies (IgG and IgM) according to patient’s characteristics
| Characteristics | Total tested n (%) | EBV VCA IgG n (%) | P | EBV VCA IgM n (%) | P |
|---|---|---|---|---|---|
| Overall cases | 272 (100) | 243 (89.2) | 152 (56.1) | ||
| Gender | 0.150 | 0.006 | |||
| Male | 143 (52.5) | 126 (88.1) | 78 (54.5) | ||
| Female | 129 (47.4) | 119 (92.7) | 74 (57.1) | ||
| Age (years) | |||||
| <10 | 33 (12.2) | 21 (63.4) | <0.001 | 11 (34.8) | <0.001 |
| 11-22 | 58 (21.4) | 39 (68.7) | 12 (20.4) | ||
| 23-32 | 37 (13.5) | 27 (72.3) | 7 (18.6) | ||
| 33-42 | 45 (16.3) | 42 (94.5) | 5 (11.3) | ||
| >43 | 99 (36.6) | 95 (95.6) | 6 (5.8) | ||
| Population group | |||||
| Children/Adolescents | 179 (65.7) | 121 (68.1) | <0.001 | 101 (56.2) | <0.001 |
| Adults/Elderly | 93 (34.3) | 61 (95.7) | 42 (44.8) | ||
| Hematological malignancies | |||||
| Hodgkin’s lymphoma (HL) | 38 (13.9) | 85 (31.4) | <0.001 | 79 (29.2) | <0.001 |
| Non-Hodgkin’s lymphoma (NHL) | 69 (25.3) | 95 (35.1) | 102 (37.7) | ||
| Acute lymphoblastic leukemia (ALL) | 101 (37.1) | 50 (20.8) | 58 (21.4) | ||
| Chronic lymphocytic leukemia (CLL) | 64 (23.5) | 34 (12.7) | 32 (11.7) |